Preview Mode Links will not work in preview mode

Eagle's Eye View: Your Weekly CV Update From

Oct 20, 2021

This week’s View examines specific effects of systolic and diastolic blood pressure on various CV outcomes, the impact of hypertensive disorders of pregnancy on the onset of chronic hypertension in the first years following first pregnancy, and a look at how far we’ve come in contemporary PCI, a comparison of SYNTAX...

Oct 13, 2021

This week’s View focuses on hypertension treatment intensification in older adults, key points on physical activity and exercise in patients with spontaneous coronary artery dissection and fibromuscular dysplasia, and CV disease risk among cigarette smokers who transitioned to vaping.

Subscribe to Eagle’s Eye...

Oct 6, 2021

This week’s View focuses on prevention: the association of statin therapy initiation and diabetes progression, the relationship between target BP and outcomes in patients with left ventricular hypertrophy, and the effects of lifestyle modifications in patients with resistant hypertension.

Subscribe to Eagle’s Eye...

Sep 29, 2021

This week’s View focuses on the effect of neprilysin inhibition on BP in patients with HFpEF and resistant hypertension, three- vs. two-drug therapy for patients with newly diagnosed pulmonary artery hypertension, and early invasive angiography in acute HF.

Sep 22, 2021

This week's View summarizes articles on empagliflozin improving CV outcomes irrespective of blood pressure, the efficacy of the COVID-19 vaccine at 6 months post-vaccination, and the protection of the COVID-19 booster dose in Israel.